ArticleBMJ open2025

Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes.

Maria Bitsch Poulsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.